Wednesday, September 17, 2014 4:25:05 PM
comment:
This means there is life still in the ole stock. There have been setbacks, because it's a competitive, cut-throat jungle in pharma & biotech phenomena.
I only have 2000 shares, and there have been price fluctuations, while I'm even now, and since it's about my patience/luck/intuition/ignorance/random/blind speculation, and the darn stock has not been a loss, I'm going to continue holding and perhaps buying some more.
I won't post it as prettier/uglier than it is.
With over 100 patents, I would think its book value plus all its experiences would be an attraction to potential partners & buyers.
So, Mr. Icahn's researcher, if you're seeing this semi terrific posting, then please tell Carl about this patent haystack.
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM